159 314

Cited 7 times in

Cited 8 times in

Earliest total vascular damage index scores independently predict all-cause mortality in patients with ANCA-associated vasculitis

DC Field Value Language
dc.contributor.authorKoo, Gyojin-
dc.contributor.authorHa, Jang Woo-
dc.contributor.authorAhn, Sung Soo-
dc.contributor.authorSong, Jason Jungsik-
dc.contributor.authorPark, Yong-Beom-
dc.contributor.authorLee, Sang-Won-
dc.date.accessioned2024-05-23T03:21:03Z-
dc.date.available2024-05-23T03:21:03Z-
dc.date.created2024-05-28-
dc.date.issued2024-04-
dc.identifier.issn0392-856X-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/199209-
dc.description.abstractObjective This study investigated whether the earliest total Vasculitis Damage Index (VDI) score could significantly predict all-cause mortality during follow-up in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Methods This study included AAV patients who were first diagnosed at this hospital from 2001 to 2022. The earliest total VDI score was defined as the first VID assessed more than 3 months after AAV diagnosis in 93.5% of patients or after the first AAV presentation in 6.5% of patients. The optimal cut-off of the earliest total VDI score for all-cause mortality was obtained using the receiver operating characteristic curve. Results The median age and earliest VDI score were 60.0 years (35.5% men), and 3.0. The most common damaged system in the earliest VDI was the pulmonary (55.3%) system. Among the AAV patients, 39 (13.3%) died. When the optimal cut-off of the earliest total VDI score for all-cause mortality was set at 3.0 (sensitivity 64.1%, specificity 75.2%), AAV patients with the earliest total VDI score ≥3.0 exhibited a significantly higher risk for all-cause mortality than those without (relative risk 6.090). AAV patients with the earliest total VDI score ≥3.0 exhibited a significantly lower cumulative patients’survival rate than those without. In the multivariable Cox hazards model analyses, not only the earliest total VDI score but also the earliest total VDI score ≥3.0 were independently associated with all-cause mortality. Conclusion This study was the first to demonstrate that the earliest total VDI score could predict all-cause mortality during follow-up in AAV patients. © Copyright Clinical and Experimental Rheumatology 2024.-
dc.description.statementOfResponsibilityopen-
dc.formatapplication/pdf-
dc.languageEnglish-
dc.publisherClinical And Experimental Rheumatology S.A.S-
dc.relation.isPartOfClinical and Experimental Rheumatology-
dc.relation.isPartOfCLINICAL AND EXPERIMENTAL RHEUMATOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleEarliest total vascular damage index scores independently predict all-cause mortality in patients with ANCA-associated vasculitis-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorKoo, Gyojin-
dc.contributor.googleauthorHa, Jang Woo-
dc.contributor.googleauthorAhn, Sung Soo-
dc.contributor.googleauthorSong, Jason Jungsik-
dc.contributor.googleauthorPark, Yong-Beom-
dc.contributor.googleauthorLee, Sang-Won-
dc.identifier.doi10.55563/clinexprheumatol/6r9eus-
dc.relation.journalcodeJ00555-
dc.identifier.eissn1593-098X-
dc.identifier.pmid38179702-
dc.subject.keywordvascular damage index-
dc.subject.keywordmortality-
dc.subject.keywordpredict-
dc.subject.keywordantineutrophil cytoplasmic antibody-
dc.subject.keywordvasculitis-
dc.contributor.alternativeNamePark, Yong Beom-
dc.contributor.affiliatedAuthorKoo, Gyojin-
dc.contributor.affiliatedAuthorHa, Jang Woo-
dc.contributor.affiliatedAuthorAhn, Sung Soo-
dc.contributor.affiliatedAuthorSong, Jason Jungsik-
dc.contributor.affiliatedAuthorPark, Yong-Beom-
dc.contributor.affiliatedAuthorLee, Sang-Won-
dc.identifier.scopusid2-s2.0-85191896008-
dc.identifier.wosid001623042000002-
dc.citation.volume42-
dc.citation.number4-
dc.citation.startPage795-
dc.citation.endPage802-
dc.identifier.bibliographicCitationClinical and Experimental Rheumatology, Vol.42(4) : 795-802, 2024-04-
dc.identifier.rimsid83966-
dc.type.rimsART-
dc.description.journalClass1-
dc.description.journalClass1-
dc.subject.keywordAuthorvascular damage index-
dc.subject.keywordAuthormortality-
dc.subject.keywordAuthorpredict-
dc.subject.keywordAuthorantineutrophil cytoplasmic antibody-
dc.subject.keywordAuthorvasculitis-
dc.subject.keywordPlusRHEUMATOLOGY CLASSIFICATION CRITERIA-
dc.subject.keywordPlus2022 AMERICAN-COLLEGE-
dc.subject.keywordPlusSYSTEMIC VASCULITIS-
dc.subject.keywordPlusALLIANCE-
dc.subject.keywordPlusGRANULOMATOSIS-
dc.type.docTypeArticle-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalWebOfScienceCategoryRheumatology-
dc.relation.journalResearchAreaRheumatology-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.